Mariko Nakano, Ph.D. - Publications

Affiliations: 
2011 University of Washington, Seattle, Seattle, WA 
Area:
Pharmacy, Biochemistry, Ophthalmology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Wiek C, Schmidt EM, Roellecke K, Freund M, Nakano M, Kelly EJ, Kaisers W, Yarov-Yarovoy V, Kramm CM, Rettie AE, Hanenberg H. Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol. The Biochemical Journal. 465: 103-14. PMID 25247810 DOI: 10.1042/Bj20140813  0.68
2014 Lockhart CM, Nakano M, Rettie AE, Kelly EJ. Generation and characterization of a murine model of Bietti crystalline dystrophy. Investigative Ophthalmology & Visual Science. 55: 5572-81. PMID 25118264 DOI: 10.1167/Iovs.13-13717  0.676
2014 Nakano M, Lockhart CM, Kelly EJ, Rettie AE. Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition. Drug Metabolism Reviews. 46: 247-60. PMID 24856391 DOI: 10.3109/03602532.2014.921190  0.695
2012 Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE. CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Molecular Pharmacology. 82: 679-86. PMID 22772592 DOI: 10.1124/Mol.112.080085  0.718
2011 Kelly EJ, Nakano M, Rohatgi P, Yarov-Yarovoy V, Rettie AE. Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. Molecular Interventions. 11: 124-32. PMID 21540472 DOI: 10.1124/Mi.11.2.10  0.722
2009 Nakano M, Kelly EJ, Rettie AE. Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2119-22. PMID 19661213 DOI: 10.1124/Dmd.109.028530  0.681
2009 McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant. Molecular Pharmacology. 75: 1337-46. PMID 19297519 DOI: 10.1124/Mol.109.054833  0.616
2005 Baer BR, Schuman JT, Campbell AP, Cheesman MJ, Nakano M, Moguilevsky N, Kunze KL, Rettie AE. Sites of covalent attachment of CYP4 enzymes to heme: evidence for microheterogeneity of P450 heme orientation. Biochemistry. 44: 13914-20. PMID 16229480 DOI: 10.1021/Bi051267J  0.531
2002 Katsuki H, Hamada A, Nakamura C, Arimori K, Nakano M. Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes. European Journal of Clinical Pharmacology. 57: 709-15. PMID 11829200 DOI: 10.1007/s002280100374  0.307
Show low-probability matches.